{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:50:16Z","timestamp":1762005016326,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.meddos.2025.04.001","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T07:16:44Z","timestamp":1748416604000},"page":"305-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incorporating organ deformation in biological modeling and patient outcome study for permanent prostate brachytherapy"],"prefix":"10.1016","volume":"50","author":[{"given":"Samantha","family":"To","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-5123","authenticated-orcid":false,"given":"Panayiotis","family":"Mavroidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-8640","authenticated-orcid":false,"given":"Ronald C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-1290","authenticated-orcid":false,"given":"Trevor","family":"Royce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2041-9074","authenticated-orcid":false,"given":"Jun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.meddos.2025.04.001_bib0001","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.pcan.4500727","article-title":"Iodine seed prostate brachytherapy: An alternative first-line choice for early prostate cancer","volume":"7","author":"Langley","year":"2004","journal-title":"Prost. Cancer Prostat. Dis."},{"issue":"23","key":"10.1016\/j.meddos.2025.04.001_bib0002","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1002\/cncr.24558","article-title":"Radiation dose escalation for localized prostate cancer: Intensity-modulated radiotherapy versus permanent transperineal brachytherapy","volume":"115","author":"Wong","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.meddos.2025.04.001_bib0003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: An analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.meddos.2025.04.001_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","article-title":"10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy","volume":"51","author":"Grimm","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.meddos.2025.04.001_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.12954\/PI.14062","article-title":"The future perspectives in transrectal prostate ultrasound guided biopsy","volume":"2","author":"Hwang","year":"2014","journal-title":"Prostate Int."},{"key":"10.1016\/j.meddos.2025.04.001_bib0006","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ultrasmedbio.2007.11.024","article-title":"Quantitative characterization of visco-elastic properties of human prostate correlated with histology","volume":"34","author":"Zhang","year":"2008","journal-title":"Ultrasound Med. Biol."},{"issue":"4","key":"10.1016\/j.meddos.2025.04.001_bib0007","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brachy.2011.11.004","article-title":"Comparison of prostate volume, shape, and contouring variability determined from preimplant magnetic resonance and transrectal ultrasound images","volume":"11","author":"Liu","year":"2012","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.meddos.2025.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ijrobp.2006.11.027","article-title":"Prostate volume contouring: A 3D analysis of segmentation using 3DTRUS, CT, and MR","volume":"67","author":"Smith","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.meddos.2025.04.001_bib0009","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1118\/1.4967481","article-title":"Prostate deformation from inflatable rectal probe cover and dosimetric effects in prostate seed implant brachytherapy","volume":"43","author":"Lian","year":"2016","journal-title":"Med. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0010","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1118\/1.3481514","article-title":"Assessment of normal tissue complications following prostate cancer irradiation: Comparison of radiation treatment modalities using NTCP models","volume":"37","author":"Takam","year":"2010","journal-title":"Med. Phys."},{"issue":"3","key":"10.1016\/j.meddos.2025.04.001_bib0011","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1016\/j.ijrobp.2020.07.567","article-title":"Patient reported outcomes of urinary toxicity after low-dose-rate prostate brachytherapy: Impact of urethral dose on urinary function","volume":"108","author":"Farris","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.meddos.2025.04.001_bib0012","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2007.07.002","article-title":"Intraoperative real-time planned conformal prostate brachytherapy: Post-implantation dosimetric outcome and clinical implications","volume":"84","author":"Zelefsky","year":"2007","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0013","doi-asserted-by":"crossref","unstructured":"Davis B.J. Horwitz E.M. Lee R.W.; et al. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy 11(1):6-19; 2012.","DOI":"10.1016\/j.brachy.2011.07.005"},{"year":"1994","series-title":"Radiobiology for the radiologist","author":"Hall","key":"10.1016\/j.meddos.2025.04.001_bib0014"},{"key":"10.1016\/j.meddos.2025.04.001_bib0015","series-title":"Current topics in clinical radiobiology of tumours","first-page":"99","article-title":"Hypoxia in tumours: Its relevance, identification and modification","author":"Horseman","year":"1993"},{"issue":"11","key":"10.1016\/j.meddos.2025.04.001_bib0016","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1118\/1.3246613","article-title":"AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of AAPM Task Group 137. AAPM","volume":"36","author":"Nath","year":"2009","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.meddos.2025.04.001_bib0017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5114\/jcb.2011.23201","article-title":"Radiobiologically based treatment plan evaluation for prostate seed implants","volume":"3","author":"Knaup","year":"2011","journal-title":"J. Contemp. Brachyther."},{"key":"10.1016\/j.meddos.2025.04.001_bib0018","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/028418699432950","article-title":"Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure","volume":"38","author":"Lind","year":"1999","journal-title":"Acta Oncol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0019","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09553009214552071","article-title":"Tumor and normal tissue responses to fractionated non uniform dose delivery","volume":"62","author":"K\u00e4llman","year":"1992","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0020","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00005650-200110000-00009","article-title":"Symptom indexes to assess outcomes of treatment for early prostate cancer","volume":"39","author":"Clark","year":"2001","journal-title":"Med. Care"},{"key":"10.1016\/j.meddos.2025.04.001_bib0021","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.meddos.2025.04.001_bib0022","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02841850500539033","article-title":"Glioma assessment using quantitative blood volume maps generated by T1-weighted dynamic contrast-enhanced magnetic resonance imaging: A receiver operating characteristic study","volume":"47","author":"Ludemann","year":"2006","journal-title":"Acta Radiol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1148\/radiol.2291010898","article-title":"Receiver operating characteristic curves and their use in radiology","volume":"229","author":"Obuchowski","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.meddos.2025.04.001_bib0024","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","article-title":"Basic principles of ROC analysis","volume":"8","author":"Metz","year":"1978","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.meddos.2025.04.001_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0026","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1088\/0031-9155\/46\/10\/307","article-title":"Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans","volume":"46","author":"Mavroidis","year":"2001","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0027","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1118\/1.598721","article-title":"Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64","volume":"26","author":"Yu","year":"1999","journal-title":"Med. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0028","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1088\/0031-9155\/52\/20\/017","article-title":"Biologically-equivalent dose and long-term survival time in radiation treatments","volume":"52","author":"Zaider","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0029","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ijrobp.2006.08.032","article-title":"Risk-adaptive optimization: Selective boosting of high-risk tumor subvolumes","volume":"66","author":"Kim","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0030","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1088\/0031-9155\/46\/10\/304","article-title":"A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd","volume":"46","author":"Antipas","year":"2001","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0031","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0360-3016(02)04208-6","article-title":"The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants","volume":"55","author":"Armpilia","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0032","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1118\/1.598415","article-title":"A calculation of the relative biological effectiveness of 125I and 103Pd brachytherapy sources using the concept of proximity function","volume":"25","author":"Wuu","year":"1998","journal-title":"Med. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0033","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0360-3016(95)00530-C","article-title":"The relative biological effectiveness of I-125 and Pd-103","volume":"32","author":"Ling","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2025.04.001_bib0034","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/02841860310012833","article-title":"Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy","volume":"42","author":"Mavroidis","year":"2003","journal-title":"Acta Oncol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00066-005-1313-y","article-title":"Dose-response relations for anal sphincter regarding fecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Radiobiological study of 65 consecutive patients","volume":"181","author":"Mavroidis","year":"2005","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0036","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1088\/0031-9155\/53\/18\/013","article-title":"A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment","volume":"53","author":"Strigari","year":"2008","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0037","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1088\/0031-9155\/48\/17\/302","article-title":"Dose escalation in permanent brachytherapy for prostate cancer: Dosimetric and biological considerations","volume":"48","author":"Li","year":"2003","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.meddos.2025.04.001_bib0038","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2004.01.047","article-title":"Assessment of I-125 prostate implants by tumor bioeffect","volume":"59","author":"Haworth","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394725000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394725000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:39:09Z","timestamp":1762004349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394725000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"alternative-id":["S0958394725000251"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2025.04.001","relation":{},"ISSN":["0958-3947"],"issn-type":[{"type":"print","value":"0958-3947"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating organ deformation in biological modeling and patient outcome study for permanent prostate brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2025.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}